Back to CRVS
PRICE T ROWE ASSOCIATES INC /MD/ → CRVS
PRICE T ROWE ASSOCIATES INC /MD/ CRVS Position History
Corvus Pharmaceuticals, Inc. • Healthcare
Quarters held
7
Latest value
$1.2M
Q3 2026
Peak value
$55M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $263K |
| Q1 2026 | $1M |
| Q1 2026 | $41.7M |
| Q2 2026 | $55M |
| Q2 2026 | $1.6M |
| Q3 2026 | $34M |
| Q3 2026 | $1.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.2M | 105.2K | — | — |
| Q3 2026 | $34M | 2.95M | — | — |
| Q2 2026 | $1.6M | 108.7K | — | — |
| Q2 2026 | $55M | 3.68M | — | — |
| Q1 2026 | $41.7M | 2.85M | — | — |
| Q1 2026 | $1M | 68.4K | — | — |
| Q4 2025 | $263K | 34.1K | — | — |
Other funds holding CRVS
$107M
$104.8M
$82.5M
$66.8M
$66.8M
$55.2M
$52.2M